Launch fatigue

Exchanges

risk-0907-30-gif

Have you ever wanted a transparent way to invest in the orthopaedic repair medical device sector? Or how about the autoimmune-inflammation pharmaceutical industry? If your answer to either of these questions is yes, then you're in luck. These are the niche sectors that New York-based financial products firm XShares hopes to target with its HealthShares exchange-traded fund (ETF) series.

The autoimmune-inflammation pharmaceutical ETF began trading on the New York Stock Exchange (NYSE) on March

To continue reading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: